AstraZeneca Admits in Court the Possibility of Thrombosis: Opinions and Reactions
In a stunning legal turn, AstraZeneca has acknowledged in court the possibility that its COVID-19 vaccine could cause thrombosis. This unprecedented step has sparked a wave of opinions and reactions worldwide. The pharmaceutical company is being sued in a class-action lawsuit for allegedly causing deaths and severe injuries in numerous cases. For the first time,…
In a stunning legal turn, AstraZeneca has acknowledged in court the possibility that its COVID-19 vaccine could cause thrombosis. This unprecedented step has sparked a wave of opinions and reactions worldwide.
The pharmaceutical company is being sued in a class-action lawsuit for allegedly causing deaths and severe injuries in numerous cases.
For the first time, AstraZeneca has admitted in court documents that its COVID-19 vaccine could cause a rare side effect, potentially paving the way for multimillion-dollar legal payouts.
Lawyers claim that the vaccine caused a devastating side effect in a small number of families.
The first case was filed in 2023 by Jaime Scott, a father of two, who was left with permanent brain damage after developing a blood clot and a brain hemorrhage that prevented him from working after receiving the vaccine in April 2021.
AstraZeneca disputes the claims but acknowledged in a legal document submitted to the High Court in February that its COVID-19 vaccine could, in rare cases, cause thrombosis with thrombocytopenia syndrome, leading to blood clots and low blood platelet counts.
The Debate on Vaccine Safety and Pharmaceutical Company Transparency
AstraZeneca’s admission was made in a legal defense against Mr. Scott’s lawsuit before the High Court. This could lead to payouts if the pharmaceutical company agrees that the vaccine was the cause of severe illness and death in specific legal cases. The government has pledged to fund AstraZeneca’s legal bills.
Lawyers argue that the AstraZeneca-Oxford vaccine is “defective” and that its efficacy has been “grossly exaggerated,” a claim that AstraZeneca strongly denies.
Scientists first identified a link between the vaccine and a new condition called vaccine-induced immune thrombotic thrombocytopenia (VITT) in March 2021, shortly after the COVID-19 vaccine rollout began.
Based on the body of evidence from clinical trials and global data, it has been demonstrated that the AstraZeneca-Oxford vaccine has an acceptable safety profile, and regulators worldwide consistently assert that the benefits of vaccination outweigh the risks of potential side effects, which are extremely rare.
While independent studies show that the AstraZeneca vaccine was incredibly effective in addressing the pandemic, saving over six million lives globally during the first year of its implementation.
The World Health Organization has stated that the vaccine was “safe and effective for all people over 18 years old” and that the adverse effect prompting the legal action was very “rare.”
The AstraZeneca vaccine is no longer used in many parts of the world where it was initially deployed.
In the months following its rollout, scientists identified the potentially serious side effects of the vaccine. It was then recommended that people under 40 be offered an alternative vaccine because the vaccine’s risk outweighed the harm presented by COVID-19.
